1. Introduction {#sec1}
===============

Skeletal muscle was recognized as a secretory organ about 15 years ago [@bib1]. Proteins and peptides produced by and released from skeletal muscles are termed myokines, and several myokines play important roles in muscle physiology as well as in tissue cross talk [@bib2], [@bib3], [@bib4]. Thus, interest in the secretory function of the skeletal muscle has increased markedly during the last decade. Physical activity alters the secretion of many myokines, several of which may play a role in mediating beneficial health effects of physical activity.

Interleukin 6 (IL6) is the most extensively studied myokine, and is secreted from skeletal muscle during acute physical activity [@bib5]. IL6 may act as an energy sensor in skeletal muscle during exercise, promoting increased hepatic glucose output and enhanced glucose uptake in muscle cells [@bib6].

More than 100 myokines have been identified [@bib7], and the skeletal muscle secretome is predicted to include more than 300 proteins [@bib8]. In several proteomics studies, scientists have identified peptides in medium conditioned by cultured human [@bib9], [@bib10], [@bib11], [@bib12] or murine myocytes [@bib13], [@bib14], [@bib15], [@bib16]. To explain some of the positive effects of physical activity, several studies focused on identifying myokines that are elevated in response to exercise or muscle contraction [@bib11], [@bib17], [@bib18], [@bib19], [@bib20].

The aim of this study was to identify novel myokines regulated by acute or long-term exercise. Many myokines, such as IL6 and other cytokines, have a low abundance in basal conditions, and are therefore hard to detect with untargeted proteomics. We used global mRNA sequencing to detect all genes expressed in human skeletal muscle biopsies. In addition, we used cultures of primary human skeletal muscle cells to monitor the expression of novel myokine candidates during differentiation and after electrical pulse stimulation (EPS).

2. Methods {#sec2}
==========

2.1. Human trial {#sec2.1}
----------------

A human exercise intervention trial ([NCT01803568](ctgov:NCT01803568){#intref0010}) was performed as described before [@bib21]. The National Committee for Research Ethics North (Tromsø, Oslo, Norway) approved the trial. This study adhered to the standards set by the Declaration of Helsinki.

Briefly, 26 sedentary (\<1 bout of exercise/week during the previous year) men aged 40--65 y with BMI 26 ± 4.0 kg/m^2^, were included in the trial. They were initially recruited to a control group (n = 13) with normal glucose metabolism and a dysglycemic group (n = 13) with fasting serum glucose ≥ 5.6 mmol/L and/or 2 h glucose ≥ 7.8 mmol/L based on an oral glucose tolerance test. Two subjects had normal glucose levels at screening, but both had a glucose infusion rate of 4.4 mg min^−1^ kg^−1^ during the euglycemic hyperinsulinemic clamp and were included in the dysglycemic group. Here we did not investigate group differences, and all subjects were therefore included (n = 26).

The participants underwent 12 weeks of supervised exercise training with two interval sessions (bicycle) and two whole-body strength-training sessions per week [@bib21]. Bicycle tests (45 min at 70% of [VO]{.smallcaps}~2~max) were conducted before and after the long-term training intervention [@bib21]. Blood samples and biopsies from *m. vastus lateralis* were collected before, immediately after, and 2 h after the acute bicycle tests ([Figure 1](#fig1){ref-type="fig"}A).

2.2. High throughput mRNA sequencing {#sec2.2}
------------------------------------

RNA was isolated from muscle biopsies and reverse-transcribed into cDNA. RNA integrity was determined using Agilent RNA 6000 Nano Chips and a Bioanalyzer 2100. Deep sequencing was performed with the Illumina HiSeq 2000 system with multiplexed design [@bib22]. The cDNA was fragmented, and cDNA fragments with 51 bp nucleotides were selected and amplified. Tophat 2.0.8 with Bowtie 2.1.0 was used (with default settings) to align the RNA-seq reads against the UCSC hg19 annotated transcriptome and genome [@bib23], [@bib24]. EdgeR v3.4.2 [@bib25] was used for gene filtering, normalization, and calculation of p-values using a negative binominal generalized linear model in R v3.0.3 (R Core Team 2014). Correction for multiple testing was performed by using Benjamini-Hochbergs false discovery rate (FDR) control [@bib26], set at FDR \< 10%. The dataset generated from RNA-seq has been used in several other publications, including one study where gene expression data for extracellular matrix (ECM) genes were reported [@bib27]. To compare our data on CSF1 with other published data sets on skeletal muscle and exercise, we analyzed two data sets [@bib28], [@bib29]. Arrays were analyzed using the R package Oligo v1.36.1 following standard procedures for quality checks and calculation of normalized expression values using robust multi-array average. For differential gene expression analyses we used the LIMMA v3.20.9.

2.3. Identification of exercise-regulated transcripts encoding secretory proteins {#sec2.3}
---------------------------------------------------------------------------------

We selected all transcripts of single genes that were up- or down-regulated more than 1.5-fold after acute or long-term exercise training. "Fast-responsive transcripts" were up/down-regulated just after the acute bicycle test (A2/A1 and/or B2/B1, [Figure 1](#fig1){ref-type="fig"}A--C), whereas "slow-responsive transcripts" were regulated after 2 h (A3/A1 and/or B3/B1, [Figure 1](#fig1){ref-type="fig"}A,D,E). The effect of long-term exercise training was assessed as the mRNA expression at B1 vs. A1 ([Figure 1](#fig1){ref-type="fig"}A,F).

To identify transcripts encoding secreted proteins, we used the MetazSecKB knowledgebase [@bib30]. MetazSecKB identifies secretory proteins based on either curated evidence of secretion (annotated and reviewed in the UniProtKB/Swiss-Prot dataset) or being "highly likely" to be secreted based on computationally predicted secretory protein sequences, without containing transmembrane domains or endoplasmic reticulum (ER) retention signals, by several tools (SignalP4, Phobius, TargetP and WoLF PSORT).

2.4. Cell culture {#sec2.4}
-----------------

Biopsies from either *m. obliquus internus abdominis* or *m. vastus lateralis* from three male donors (age 33--62 y) were used to isolate primary human satellite cells [@bib31]. Myoblasts were proliferated to passage 4--5 and differentiated [@bib27]. EPS (1 Hz, 2 ms, 11.5 V) was applied to the cells after 5 days of differentiation for 24 h or after 6 days of differentiation for 1--6 h. EPS should mimic muscle contraction similar to *in vivo* exercise [@bib32]. Supernatants were collected and RNA isolated for further analysis.

2.5. Protein analyses {#sec2.5}
---------------------

We measured CSF1 concentration in the supernatant of cultured myotubes and plasma samples using a human CSF1 ELISA Kit (DMC00B; R&D Systems Minneapolis; Minnesota, United States). Total protein concentration of plasma was measured by BC Assay (Protein assay kit, Uptima, Montlucon, France).

2.6. RNA isolation, cDNA synthesis and gene expression analyses {#sec2.6}
---------------------------------------------------------------

Total RNA was isolated from cultured cells using the RNeasy Mini kit (Qiagen, Hilden, Germany). RNA was reversely transcribed into cDNA using the High Capacity cDNA Revers Transferase kit (ThermoFisher, Foster City, California, United States). Quantitative real-time PCR was performed using the CFX96™ Real-Time System (Bio-Rad, Hercules, California, USA). The following pre-designed primers and probe sets were used (TaqMan assays; ThermoFisher, Foster City, California, United States) RPLP0 (Hs99999902_m1), MTRNR2L4 (Hs04276154_s1), SMPDL3A (Hs00378308_m1), FAM20C (Hs00398243_m1), WNT9A (Hs00243321_m1), TEK (Hs00945155_m1), FLT1 (Hs01052961_m1), CSF1 (Hs00174164_m1), C8G (Hs01113922_g1), CHSY1 (Hs00208704_m1), IL4R (Hs00166237_m1), LCN10 (Hs01596612_g1), STC2 (Hs00175027_m1), THBS4 (Hs00170261_m1), IGFBP2 (Hs01040719_m1), KAZALD1 (Hs00368867_g1), TNFRSF25 (Hs00600930_g1), and SCT (Hs00360814_g1). Relative target mRNA expression levels were calculated as 2^-\ ΔCt^ by normalizing to the expression of *RPLP0*.

3. Results {#sec3}
==========

3.1. Fast exercise-responsive transcripts {#sec3.1}
-----------------------------------------

To identify myokines up-regulated by acute exercise, we evaluated gene transcription in skeletal muscle biopsies immediately after two acute, 45 min bicycle tests ([Figure 1](#fig1){ref-type="fig"}A). After the first bicycle test (A2/A1), 551 transcripts were more than 1.5-fold up-regulated, and 97 of these were classified as secretory ([Figure 1](#fig1){ref-type="fig"}B, [Supplementary Table 1](#appsec1){ref-type="sec"}). After the second bicycle test (after the exercise intervention; B2/B1), 587 transcripts were enhanced (\>1.5-fold), and 108 of these encode secretory proteins ([Figure 1](#fig1){ref-type="fig"}C, [Supplementary Table 2](#appsec1){ref-type="sec"}). In total, we identified 117 secretory transcripts that were increased immediately after acute exercise (\>1.5-fold at A2/A1 and/or B2/B1, [Figure 2](#fig2){ref-type="fig"}A, [Table 1](#tbl1){ref-type="table"}). There was extensive overlap in expression pattern between the two bicycle tests; 88 transcripts were detected after both tests ([Figure 2](#fig2){ref-type="fig"}A). Furthermore, 95 of the 97 genes detected after the first test were also up-regulated after the second test (FC \> 1, p-value \< 0.05), although not necessarily to above the 1.5-fold cut-off ([Supplementary Table 1](#appsec1){ref-type="sec"}).

Many of these fast-responding transcripts encode cytokines or chemokines, with *IL6* being the most up-regulated gene. Other examples were *IL1B, CXCL1, CXCL2, CXCL3* and *CXCL8, CCL2*, and *CCL8*. These cytokines and chemokines were typically expressed at very low levels at baseline, but were markedly increased after exercise ([Table 1](#tbl1){ref-type="table"}). Furthermore, most of them returned to basal levels after 2 h rest.

Other fast-responding transcripts encode growth factors (*CTGF, FGF6, FGF18, PDGFA, PDGFB, TGFB3, VEGFA*, and *VEGFC*) or proteases and protease inhibitors involved in ECM remodeling (*ADAMTS4, ADAMTS1, PLAU, MMP19, ADAM8,* S*ERPINE1, SERPINH1, SERPINA3*, and *TIMP1*). We have previously published and discussed results related to ECM [@bib27].

Only a few secretory transcripts were down-regulated after acute exercise; 14 and 17 transcripts were identified after the first (A2/A1) and second (B2/B1) bicycle test, respectively ([Figure 2](#fig2){ref-type="fig"}E, [Supplementary Tables 3 and 4](#appsec1){ref-type="sec"}).

3.2. Slow exercise-responsive transcripts {#sec3.2}
-----------------------------------------

Two hours after the first bicycle test (A3/A1), 501 transcripts were increased \>1.5-fold, and of these, 83 were classified as secretory ([Figure 1](#fig1){ref-type="fig"}D, [Supplementary Table 5](#appsec1){ref-type="sec"}). Furthermore, 274 transcripts were up-regulated 2 h after the second bicycle test (B3/B1), and 49 of these were secretory ([Figure 1](#fig1){ref-type="fig"}E, [Supplementary Table 6](#appsec1){ref-type="sec"}). In total, we detected 91 secretory transcripts that were increased 2 h after either of the two tests ([Table 2](#tbl2){ref-type="table"}, [Figure 2](#fig2){ref-type="fig"}B). Some of these slow-responsive transcripts encode cytokines and growth factors (*INHBE*, *TGFB3*, *CLCF1*, *VEGFA* and *CCL2*) and proteases and protease inhibitors (*PLG, SERPINA1, SERPINA3, SERPINF2, ADAMTS8, ADAMTS9* and *ADAM8*).

The gene expression response was generally stronger after the first bicycle test as compared with the second; a higher number of transcripts were identified after the first bicycle test ([Figure 2](#fig2){ref-type="fig"}B). Furthermore, of the 91 secretory transcripts detected, 77 increased more after the first test as compared with the second test ([Table 2](#tbl2){ref-type="table"}). Still, there was a substantial overlap between the results; 71 of the 83 transcripts detected after the first bicycle test were also significantly increased after the second test (FC \> 1, p \< 0.05, [Supplementary Table 5](#appsec1){ref-type="sec"}).

Several secretory transcripts were down-regulated 2 h after bicycling; 60 and 35 secretory transcripts were decreased (\>1.5-fold) after the first (A3/A1) and second (B3/B1) bicycle test, respectively ([Figure 1](#fig1){ref-type="fig"}, [Figure 2](#fig2){ref-type="fig"}F, [Supplementary Tables 7 and 8](#appsec1){ref-type="sec"}).

3.3. Transcripts regulated after long-term training {#sec3.3}
---------------------------------------------------

After 12 weeks exercise intervention, 289 transcripts were increased \>1.5-fold in skeletal muscle (B1/A1). Of these, 99 were classified as secretory ([Figure 1](#fig1){ref-type="fig"}F, [Table 3](#tbl3){ref-type="table"}, [Supplementary Table 1](#appsec1){ref-type="sec"}). The transcript encoding matrix-remodeling associated protein 5 (*MXRA5*) had the highest relative increase (2.8-fold). *SPARC* exhibited the highest expression level at baseline (71.5 FPKM) and was increased 1.8-fold after the intervention.

A large proportion of the up-regulated transcripts after long-term training were related to ECM ([Table 3](#tbl3){ref-type="table"}). We identified 10 collagens (e.g. collagen type I, III, IV), proteoglycans (e.g. *AGRN*, *LUM* and *BGN*) and a variety of ECM glycoproteins (e.g. *LAMB1*, *SPARC*, *NID1* and *ELN*). Some of these data were recently reported and discussed in another publication [@bib27].

Only 9 transcripts encoding secretory proteins were decreased \>1.5-fold in skeletal muscle after 12 weeks of intervention (B1/A1) ([Figure 1](#fig1){ref-type="fig"}F, [Supplementary Table 10](#appsec1){ref-type="sec"}). One of these transcripts encodes *MSTN* (FC = −1.7), which is a negative regulator of muscle growth. This result was recently reported and discussed in another publication [@bib33].

3.4. Transcripts up-regulated after both acute and long-term exercise {#sec3.4}
---------------------------------------------------------------------

In total, we detected 161 unique secretory transcripts that were up-regulated after acute exercise (post-immediate and/or after 2 h; [Figure 2](#fig2){ref-type="fig"}C) and 99 transcripts that were increased after 12 weeks exercise intervention. We detected 12 genes that were up-regulated \>1.5-fold after both acute and long-term exercise ([Figure 2](#fig2){ref-type="fig"}D). However, a large number of acute genes were also significantly increased after 12 weeks training, although below the 1.5-fold cut-off. For instance, of the transcripts that increased \>1.5-fold after the first bicycle test (A2/A1), more than half were significantly increased (FC \> 1, p-value \< 0.05) after 12 weeks training (B1/A1, [Supplementary Table 1](#appsec1){ref-type="sec"}).

Some transcripts encode well-known myokines, whereas others have never been studied in skeletal muscle. Approximately half of these myokines have previously been detected by mass spectrometry or antibody arrays in medium conditioned by cultured human or murine skeletal muscle cells [@bib9], [@bib10], [@bib11], [@bib12], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18], [@bib19], [@bib20], [@bib34], [@bib35], [@bib36] ([Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}, [Table 3](#tbl3){ref-type="table"}). About 70% of the transcripts we identified encode curated, secreted proteins, whereas the rest encode proteins that are "highly likely" to be secreted. Some of these "highly likely" secreted proteins are mostly considered intracellular, but may have secreted isoforms.

3.5. Expression of novel myokines in primary human skeletal muscle cells {#sec3.5}
------------------------------------------------------------------------

Several of the transcripts we identified have not been studied previously in skeletal muscle and may encode novel myokines. We selected 17 candidates exhibiting enhanced expression after acute and/or long-term training ([Supplementary Figure 1](#appsec1){ref-type="sec"}). The candidates were chosen based on the expression level in skeletal muscle and the magnitude of change in response to exercise. We prioritized genes that may encode myokines with potential endocrine functions over ECM-related factors.

We chose the following candidates: stanniocalcin 2 (*STC2*), insulin like growth factor binding protein 2 (*IGFBP2*), family with sequence similarity 20 member C (*FAM20C*), *CSF1*, secreted frizzled related protein 4 (*SFRP4*), tumor necrosis factor receptor superfamily member 25 (*TNFRSF25*), IL4 receptor (*IL4R*), chondroitin sulfate synthase 1 (*CHSY1*), kazal type serine peptidase inhibitor domain 1 (*KAZALD1*), angiopoietin-1 receptor (*TEK*), sphingomyelin phosphodiesterase acid like 3A (*SMPDL3A*), thrombospondin 4 (*THBS4*), complement component 8 gamma polypeptide (*C8G*), humanin-like 4 (*MTRNR2L4*), wnt family member 9A (*WNT9A*), Fms related tyrosine kinase 1 (*FLT1*), and lipocalin 10 (*LCN10*).

All mRNAs except *WNT9A*, *FLT1*, and *LCN10* were expressed in cultured muscle cells ([Figure 3](#fig3){ref-type="fig"}B). The relative expression levels of the investigated mRNAs showed differences between *in vitro* differentiated myotubes and skeletal muscle biopsies. *MTRNR2L4* and *THBS4* were highly expressed in biopsies, whereas in cultured myotubes the expression was low. In myotubes *STC2* was highly expressed, which was not the case in skeletal muscle biopsies.

To investigate mRNA expression during myogenic differentiation, myoblasts were differentiated to multinuclear myotubes for 7 days ([Figure 3](#fig3){ref-type="fig"}C--F). During myogenesis, *THBS4* (4-fold), *FAM20C* (2.3-fold), *CHSY1* (1.5-fold), *TEK* (2.5-fold), *IGFBP2* (3-fold), *TNFRSF25* (3.5-fold), and *KAZALD1* (2-fold) all increased significantly, whereas *STC2* was the only gene that was down-regulated (−3.3-fold; [Figure 3](#fig3){ref-type="fig"}C). *MTRNR2L4*, *SMPDL3, CSF1, C8G*, and *IL4R* were not significantly changed (data not shown).

To gain further insight into the exercise-related regulation of gene expression, cultured myotubes were subjected to EPS for 24 h to induce myotube contraction ([Figure 3](#fig3){ref-type="fig"}G). EPS increased the expression of *PPARGC1A* and *IL6*, 1.3- and 3-fold, respectively, as previously shown [@bib27]. However, only *CSF1* was significantly up-regulated by 24 h EPS (1.3-fold, p \< 0.05), whereas *FAM20C* expression was reduced −1.25-fold (p \< 0.05).

3.6. CSF1 is secreted from human skeletal muscle cells {#sec3.6}
------------------------------------------------------

Because *CSF1* expression was enhanced in skeletal muscle after acute exercise ([Figure 4](#fig4){ref-type="fig"}A) and in cultured myotubes after 24 h EPS ([Figure 3](#fig3){ref-type="fig"}G), we further focused on CSF1. The expression of CSF1 was also slightly (9%) increased in muscle after 12 weeks. Interestingly, the expression of CSF1 receptor (*CSF1R*) in skeletal muscle increased after 12 weeks exercise training ([Figure 4](#fig4){ref-type="fig"}B). We also measured CSF1 concentration in plasma samples from participants, before (n = 26) and after (n = 22) the 12 weeks intervention. Plasma concentration of CSF1 was significantly increased immediately after exercise, and was reduced to below baseline after 2 h recovery ([Figure 4](#fig4){ref-type="fig"}C). Acute exercise may influence plasma volume and protein concentration [@bib37], however total protein concentration was measured and did not change significantly during acute exercise in our study. Interestingly, the concentration of CSF1 also increased after 12 weeks exercise training (33%, p = 0.03).

In addition to 24 h EPS, short-term EPS enhanced CSF1 expression 2.4-fold after 2 h ([Figure 4](#fig4){ref-type="fig"}D). Furthermore, we measured CSF1 concentration in cell culture medium collected from myotubes after 24 h with or without EPS ([Figure 4](#fig4){ref-type="fig"}E). Although the baseline concentration of CFS1 in supernatants of myotubes differed substantially between the donors ranging from 38 pg/mL to 310 pg/mL, we observed that EPS increased CSF1 concentration in all experiments, promoting an increase of 1.5-fold (p \< 0.05). This suggests that CSF1 is an exercise-responsive myokine secreted from human skeletal muscle cells.

4. Discussion {#sec4}
=============

In the present study, we used mRNA sequencing as an untargeted screening to identify exercise-responsive myokines. We searched for secretory transcripts that were either up- or down-regulated, although we chose to focus on myokines that were increased by exercise. In total, we detected almost 250 genes encoding putative myokines that were up-regulated after acute and/or long-term training. About half of these proteins have not been detected by previous proteomics studies on skeletal muscle cell cultures. To our knowledge, there are no published studies that have used mRNA sequencing to search for new myokines, which is a useful approach to substantially expand our knowledge of the skeletal muscle secretome. Most transcripts followed different patterns of expression; some were "fast" or "slow" responders to exercise, whereas others responded to long-term exercise, or both. Moreover, several transcripts responded differently to acute exercise after long-term exercise.

Several other studies have focused on the transcriptional response in skeletal muscle to physical activity. Catoire et al. used microarray to measure gene expression after 1 h one-legged cycling or 12 weeks of combined exercise training [@bib17]. The authors identified 52 putative myokines that were significantly (p \< 0.01) up-regulated in the exercising leg after acute exercise and 66 that were induced after 12 weeks training. Interestingly, these data are in concordance with our RNA-seq data; of the 52 acute transcripts identified by Catoire et al., 50 were also increased in our dataset (A2/A1, p \< 0.05). Furthermore, of the 66 putative myokines induced after 12 weeks, 62 were also significantly up-regulated in our participants (B1/A1).

After acute exercise, several cytokines, chemokines, growth factors and ECM remodeling enzymes were up-regulated. Several of these are known contraction-regulated myokines, including IL6, IL8, LIF, CCL2, CX3CL1, SERPINE1, ANGPTL4, and VEGF [@bib17], [@bib38]. Because many myokines and cytokines are difficult to detect by the use of mass spectrometry, antibody arrays have been used as a tool for myokine discovery. Raschke et al. used a cytokine antibody array to detect proteins released from cultured human muscle cells in response to electrical stimulation [@bib19]. In total, they identified 45 proteins that were induced by EPS, and many of them were cytokines, chemokines, or growth factors. About half were up-regulated after acute or long-term exercise in our participants (p \< 0.05, B1/A1).

After long-term training, a large proportion of the up-regulated transcripts were related to ECM. Induction of ECM related genes after exercise training has been reported by several others [@bib17], [@bib39], [@bib40], [@bib41]. We have discussed the data related to ECM in more detail elsewhere [@bib27].

We used primary human skeletal muscle cells as a model system for further investigation of 17 novel myokine candidates *in vitro*. Cultured human myotubes share many morphological and biochemical characteristics with skeletal muscle fibers *in vivo* [@bib42], [@bib43]. They are multinucleated and have the ability to contract upon electrical stimulation. The relative expression levels of the 17 selected candidates were different in cultured cells as compared to muscle biopsies; some of the most highly expressed transcripts in biopsies were expressed at low levels *in vitro* and *vice versa*. *IL6, STC2*, and *CSF1* were all higher expressed in cultured myotubes than in muscle tissue (relative to the expression of *RPLP0*). Moreover, three transcripts were not expressed in cultured myotubes. Gene expression patterns in cultured myotubes vs. skeletal muscle have been investigated previously. Raymond et al. reported lower expression of genes involved in metabolism, mitochondria, and muscle contraction, whereas genes related to ECM and apoptosis were more highly expressed [@bib44]. Muscle cell cultures are isolated systems that lack *in vivo* microenvironment, innervation and communication with other cells and organs [@bib43]. Furthermore, cultured myotubes are not as differentiated as muscle fibers *in vivo*. Although most cells in culture merge to form multinuclear myotubes, a fraction of undifferentiated and atrophic cells can be found [@bib45]. Lastly, unlike cell cultures, skeletal muscle tissue contains many different cell types such as endothelial cells, neuronal cells, and fibroblasts. This may explain the difference in gene expression between muscle biopsies and cultured myotubes.

We focused on CSF1, because *CSF1* mRNA levels were increased after acute and long-term exercise in skeletal muscle and in cultured skeletal muscle cells after EPS. The concentration of CSF1 was increased in plasma after acute and long-term exercise and in medium conditioned by cultured myotubes after EPS. By investigating the expression of *CSF1* in publically available transcriptomic datasets from human skeletal muscle, we also know that CSF1 is influenced by several types of acute exercise. A single bout of endurance or strength training increased the expression of *CSF1* (p \< 0.05) 2.5 h after the exercise bout (1.5- and 1.6-fold, respectively) [@bib29]. At 5 h post-exercise the *CSF1* expression levels were returned to baseline. Furthermore, 3 h after an eccentric exercise bout *CSF1* expression was increased 1.4-fold [@bib28].

CSF1, also known as macrophage-CSF, is a cytokine and an important hematopoietic growth factor [@bib46], inducing differentiation of myeloid progenitors into monocytes, macrophages, dendritic cells and bone-resorbing osteoclasts [@bib47]. CSF1 is a central regulator of macrophage numbers in tissues, and injecting mice with recombinant CSF1 induces a marked increase in number of blood monocytes. CSF1 may influence macrophage survival, proliferation, differentiation, and function, and CSF1 has been linked to diseases like arthritis, cancer, nephritis, pulmonary fibrosis, atherosclerosis, and vascular injury [@bib48], [@bib49], [@bib50].

Based on our data, we hypothesize that CSF1 mediates cross-talk between skeletal muscle cells and immune cells and could be involved in exercise-induced immune responses. It is also possible that CSF1 may have other functions during exercise. Several of the previously described myokines are cytokines with immune-regulatory functions. For instance, IL6 was originally identified as a proinflammatory cytokine secreted from T-cells and macrophages, whereas exercise-induced IL6 is not associated with muscle damage and inflammation, but has been linked to metabolic regulation [@bib5], [@bib6].

Alternative functions of CSF1 during exercise may be related to muscle adaptation. Incubation of skeletal muscle cells or monocytes with CSF1 promotes increased VEGF production and angiogenesis [@bib51], [@bib52]. VEGF promotes angiogenesis by stimulating proliferation of endothelial cells [@bib53]. Our data demonstrate increased expression of both *VEGFA* and CSF1 after exercise, which might be important for skeletal muscle vascularization.

Several lines of evidence suggest that CSFs may reduce serum lipids and cholesterol levels. Human CSF1 was injected to 7 boys with chronic neutropenia. After 7 days treatment, absolute neutrophil numbers increased in 4 patients, but serum cholesterol levels were reduced in all of them [@bib54]. Shimano et al. injected rabbits with recombinant CSF1 for 7 days, lowering plasma cholesterol levels by 33% [@bib55]. Moreover, CSF1 may modulate lipoprotein metabolism by promoting macrophages to produce lipoprotein lipase (LPL) [@bib56]. Thus, enhanced plasma concentration of CSF1 after acute exercise may influence lipid metabolism and lower cholesterol levels.

In summary, we identified numerous transcripts that were regulated in skeletal muscle after acute and/or long-term exercise. These transcripts encode potential myokines, which may play key roles in local and systemic adaptations to exercise. Furthermore, we identified CSF1 as a novel myokine, which was increased after acute and long-term exercise, and secreted from cultured human myotubes in response to EPS.
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![A) Overview of the study design. Skeletal muscle biopsies and blood samples were harvested before (A1, B1), immediately after (A2, B2) and 2 h after (A3, B3) the end of the bicycle sessions. B--F) Secretory genes up- or down-regulated \>1.5-fold at one or several time-points after acute or long-term exercise. Log2 (FC) from baseline (A1 or B1). Blue dots represent up-regulated genes, purple triangles represent down-regulated genes. B) Genes up- or down-regulated \>1.5-fold at A2/A1. C) Genes up- or down-regulated \>1.5-fold at B2/B1. D) Genes up- or down-regulated \>1.5-fold at A3/A1. E) Genes up- or down-regulated \>1.5-fold at B3/B1. F) Genes up- or down-regulated \>1.5-fold after 12 weeks exercise training (B1/A1).](gr1){#fig1}

![Venn diagrams showing the number of secretory genes that were up- or down-regulated \>1.5-fold at different time points after acute and/or long-term exercise.](gr2){#fig2}

![A--B) mRNA expression of selected genes in skeletal muscle biopsies (in A1, n = 26) or cultured human myotubes. mRNA expression in biopsies was determined with RNA-seq, and in myotubes by RT-PCR from 5--6 experiments using different donors. C--F) Primary human myoblasts were differentiated to multinucleated myotubes for 7 days. mRNA expression values are shown as fold change from the expression in myoblasts (day 0) and represent means + SEM from 3--4 experiments using different donors. \*p \< 0.05 vs. D0, students *t*-test. G) Primary human skeletal muscle cells were differentiated for 5 days and subjected to electrical pulse stimulation (EPS; 1 Hz, 2 ms, 11.5 V) for 24 h. Data are shown as fold vs. control and represent means + SEM from 5--7 experiments. \*p \< 0.05, students *t*-test. Gene expression values were normalized to *RPLP0*, bars depict means + SEM.](gr3){#fig3}

![A) mRNA expression of CSF1 and B) CSF1 receptor (CSF1R) in skeletal muscle biopsies at baseline (A1--A3) and after 12 weeks (B1--B3), \*p \< 0.05 vs. A1, \$ p \< 0.05 vs. B1, p-values obtained using paired *t*-test. C) Plasma CSF1 before (n = 26) and after (n = 22) the 12 weeks intervention. Data are shown as absolute values, means + SEM. \*p \< 0.05 vs. A1, \$ p \< 0.05 vs B1, paired *t*-test. D) Human skeletal muscle cells were differentiated for 6 days and subjected to acute EPS up to 6 h. mRNA expression was determined by RT-PCR, and gene expression values were normalized to expression of *RPLP0*. \*p \< 0.05 vs. unstimulated cells (*t*-test), n = 4--5. E) Myotubes were left unstimulated (control) or subjected to 24 h EPS, and supernatants were collected. CSF1 concentration was determined by ELISA. Data are shown as absolute values (left panel) and fold vs. control (right panel) and represent means + SEM, \*p \< 0.05 (*t*-test), n = 5.](gr4){#fig4}

###### 

Transcripts up-regulated just after 45 min acute exercise of 70% of VO~2~max.

Table 1

  Symbol      Gene name                                                   FPKM A1[a](#tbl1fna){ref-type="table-fn"}   FPKM B2   A2/A1                                B2/B1                                Metaz-SecKB[d](#tbl1fnd){ref-type="table-fn"}   Detected in CM                                               
  ----------- ----------------------------------------------------------- ------------------------------------------- --------- ------------------------------------ ------------------------------------ ----------------------------------------------- ---------------- ------------------------------------------- --------------------------------------------------
  IL6         Interleukin 6                                               0.09                                        0.12      65.4                                 9E-28                                50.8                                            2E-20            Curated                                     Antibody array[g](#tbl1fng){ref-type="table-fn"}
  CXCL8       Interleukin 8                                               0.03                                        0.04      29.1                                 3E-21                                34.4                                            7E-12            Curated                                     Antibody array[g](#tbl1fng){ref-type="table-fn"}
  CXCL1       Chemokine (C-X-C motif) ligand 1                            0.05                                        0.08      26.2                                 3E-59                                18.9                                            1E-34            Curated                                     Antibody array[g](#tbl1fng){ref-type="table-fn"}
  CCL8        Chemokine (C-C motif) ligand 8                              0.07                                        0.13      24                                   5E-33                                18.1                                            6E-40            Curated                                     Antibody array[g](#tbl1fng){ref-type="table-fn"}
  ADAMTS4     ADAM metallopeptidase with thrombospondin type 1 motif 4    0.38                                        0.58      18.9                                 3E-64                                19.2                                            1E-32            Curated                                     MS Murine
  PTGS2       Prostaglandin-endoperoxide synthase 2                       0.02                                        0.03      17.3                                 2E-32                                18.5                                            2E-25            Highly likely                               --
  CXCL2       Chemokine (C-X-C motif) ligand 2                            1.21                                        2.14      14.5                                 8E-35                                9.7                                             8E-23            Curated                                     --
  CCL2        Chemokine (C-C motif) ligand 2                              2.25                                        3.31      12.9                                 5E-16                                13.5                                            3E-18            Curated                                     Antibody array[g](#tbl1fng){ref-type="table-fn"}
  CXCL3       Chemokine (C-X-C motif) ligand 3                            0.09                                        0.15      10.1                                 1E-21                                5.9                                             6E-13            Curated                                     --
  IL1B        Interleukin 1, beta                                         0.05                                        0.04      9.3                                  2E-19                                21.5                                            9E-21            Curated                                     Antibody array[g](#tbl1fng){ref-type="table-fn"}
  THBS1       Thrombospondin 1                                            0.4                                         0.75      8.6                                  6E-21                                7.5                                             1E-12            Highly likely                               MS hSkMC
  CYR61       Cysteine-rich, angiogenic inducer, 61                       9.29                                        12.53     8                                    9E-38                                4.6                                             2E-30            Curated                                     MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  ADAMTS1     ADAM metallopeptidase with thrombospondin type 1 motif, 1   5.87                                        6.86      7.2                                  1E-82                                6.9                                             7E-55            Curated                                     MS hSkMC[i](#tbl1fni){ref-type="table-fn"}
  PLAUR       Plasminogen activator, urokinase receptor                   0.32                                        0.46      7.1                                  2E-54                                7.3                                             2E-26            Curated                                     MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  LIF         Leukemia inhibitory factor                                  0.06                                        0.09      6.5                                  4E-13                                5                                               3E-08            Curated                                     Antibody array[g](#tbl1fng){ref-type="table-fn"}
  STC1        Stanniocalcin 1                                             0.12                                        0.22      6                                    3E-28                                4.7                                             3E-12            Curated                                     MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  SERPINE1    Serpin peptidase inhibitor, clade E, member 1               0.78                                        1.33      4.8                                  5E-26                                4.3                                             2E-13            Curated                                     Antibody array[g](#tbl1fng){ref-type="table-fn"}
  F2RL3       F2R like thrombin/trypsin receptor 3                        0.18                                        0.29      4.7                                  1E-20                                3.2                                             3E-08            Highly likely                               --
  LDLR        Low density lipoprotein receptor                            1.31                                        1.66      4.3                                  9E-83                                4.5                                             9E-37            Highly likely                               MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  INHBB       Inhibin, beta B                                             0.49                                        0.70      4.1                                  2E-46                                4.7                                             9E-37            Curated                                     MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  ICAM1       Intercellular adhesion molecule 1                           2.1                                         2.56      3.9                                  2E-20                                3.7                                             2E-14            Highly likely                               MS hSkMC[i](#tbl1fni){ref-type="table-fn"}
  ANGPTL4     Angiopoietin-like 4                                         0.52                                        0.55      3.7                                  1E-12                                7.2                                             1E-24            Curated                                     MS hSkMC[i](#tbl1fni){ref-type="table-fn"}
  PLAU        Plasminogen activator, urokinase                            2.58                                        3.38      3.6                                  2E-19                                4.3                                             2E-20            Curated                                     MS hSkMC[i](#tbl1fni){ref-type="table-fn"}
  CHGB        Chromogranin B                                              0.25                                        0.31      3.3                                  7E-10                                3.1                                             6E-11            Curated                                     --
  LRRC32      Leucine rich repeat containing 32                           4.11                                        5.59      3.2                                  8E-67                                2.7                                             6E-47            Highly likely                               --
  FUT1        Fucosyltransferase 1 (H blood group)                        0.74                                        0.92      3.2                                  1E-74                                2.5                                             3E-31            Highly likely                               --
  TNFAIP6     TNF alpha induced protein 6                                 0.5                                         0.62      3.2                                  7E-13                                3.5                                             2E-12            Highly likely                               --
  CTGF        Connective tissue growth factor                             6.58                                        10.37     3.1                                  6E-26                                2.4                                             6E-19            Curated                                     MS hSkMC[i](#tbl1fni){ref-type="table-fn"}
  SERPINH1    Serpin family H member 1                                    6.71                                        11.42     3                                    2E-41                                2.3                                             8E-28            Highly likely                               MS hSkMC[i](#tbl1fni){ref-type="table-fn"}
  FGF6        Fibroblast growth factor 6                                  7.46                                        6.00      2.9                                  2E-22                                2                                               8E-07            Curated                                     Antibody array[g](#tbl1fng){ref-type="table-fn"}
  PTX3        Pentraxin 3, long                                           0.09                                        0.12      2.8                                  4E-03                                3.8                                             2E-04            Curated                                     MS hSkMC[i](#tbl1fni){ref-type="table-fn"}
  FCGR3B      Fc fragment of IgG, low affinity IIIb, receptor (CD16b)     0.13                                        0.13      2.8                                  2E-06                                6.8                                             6E-15            Curated                                     --
  METRNL      Meteorin, glial cell differentiation regulator-like         1.37                                        1.68      2.7                                  1E-28                                2.7                                             3E-17            Curated                                     MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  SEMA4C      Semaphorin 4C                                               3.11                                        3.38      2.7                                  1E-77                                2.5                                             7E-51            Highly likely                               MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  INHBE       Inhibin, beta E                                             0.42                                        0.66      2.7                                  4E-33                                2.2                                             1E-19            Curated                                     --
  CLCF1       Cardiotrophin-like cytokine factor 1                        0.22                                        0.32      2.6                                  7E-15                                2.8                                             1E-15            Curated                                     --
  TNFRSF12A   Tumor necrosis factor receptor superfamily member 12A       6.53                                        10.35     2.5                                  1E-18                                2.3                                             3E-14            Highly likely                               --
  SAA1        Serum amyloid A1                                            1.64                                        4.05      2.5                                  7E-09                                2.1                                             1E-02            Curated                                     --
  S100A9      S100 calcium binding protein A9                             1.97                                        2.23      2.5                                  2E-07                                3.9                                             5E-10            Curated                                     --
  CX3CL1      Chemokine (C-X3-C motif) ligand 1                           3.87                                        5.19      2.4                                  6E-15                                2.2                                             4E-13            Curated                                     Antibody array[g](#tbl1fng){ref-type="table-fn"}
  SAA2        Serum amyloid A2                                            0.21                                        0.26      2.4                                  5E-11                                2.2                                             3E-05            Curated                                     --
  FGF18       Fibroblast growth factor 18                                 0.22                                        0.16      2.3                                  1E-08                                2.8                                             2E-08            Curated                                     --
  SECTM1      Secreted and transmembrane 1                                0.34                                        0.40      2.3                                  2E-12                                2.7                                             4E-08            Curated                                     MS hSkMC[i](#tbl1fni){ref-type="table-fn"}
  S100A8      S100 calcium binding protein A8                             1.01                                        1.24      2.3                                  6E-05                                4.6                                             2E-10            Curated                                     --
  MMP19       Matrix metallopeptidase 19                                  0.25                                        0.35      2.2                                  2E-05                                3                                               3E-09            Curated                                     MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  SRGN        Serglycin                                                   7.81                                        11.94     2.2                                  1E-50                                2                                               4E-18            Curated                                     MS hSkMC[i](#tbl1fni){ref-type="table-fn"}
  CCL21       Chemokine (C-C motif) ligand 21                             0.35                                        1.21      2.2                                  5E-02                                0.5                                             2E-01            Curated                                     Antibody array[g](#tbl1fng){ref-type="table-fn"}
  CSF3R       Colony stimulating factor 3 receptor (granulocyte)          0.32                                        0.49      2.2                                  9E-06                                3                                               1E-07            Curated[e](#tbl1fne){ref-type="table-fn"}   --
  RELT        RELT tumor necrosis factor receptor                         3.3                                         2.90      2.2                                  5E-28                                2.1                                             3E-19            Highly likely                               --
  ITGA5       Integrin subunit alpha 5                                    4.42                                        6.48      2.2                                  3E-46                                1.9                                             2E-21            Highly likely                               MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  IL4R        Interleukin 4 receptor                                      1.17                                        1.73      2.2                                  1E-34                                2.1                                             6E-14            Curated                                     MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  EPHA2       EPH receptor A2                                             1.58                                        2.08      2.1                                  1E-39                                1.9                                             9E-16            Highly likely                               MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  CHSY1       Chondroitin sulfate synthase 1                              1.4                                         1.82      2.1                                  2E-31                                2.3                                             2E-20            Curated                                     --
  VEGFA       Vascular endothelial growth factor A                        47.33                                       50.63     2                                    2E-42                                1.8                                             2E-24            Curated                                     Antibody array[g](#tbl1fng){ref-type="table-fn"}
  IL7R        Interleukin 7 receptor                                      0.09                                        0.12      2                                    2E-08                                2.5                                             7E-10            Curated                                     --
  SERPINA1    Serpin peptidase inhibitor, clade A, member 1               0.16                                        0.22      1.9                                  3E-05                                2.3                                             4E-05            Curated                                     --
  SDC4        Syndecan 4                                                  16.5                                        15.64     1.9                                  8E-27                                1.9                                             9E-20            Curated                                     MS hSkMC[i](#tbl1fni){ref-type="table-fn"}
  GDNF        Glial cell derived neurotrophic factor                      3.98                                        3.36      1.9                                  4E-12                                1.8                                             2E-05            Curated                                     Antibody array[g](#tbl1fng){ref-type="table-fn"}
  GFPT2       Glutamine-fructose-6-phosphate transaminase 2               1.04                                        1.15      1.9                                  5E-09                                1.8                                             8E-05            Highly likely                               --
  PDGFA       Platelet-derived growth factor alpha polypeptide            5.54                                        5.41      1.9                                  4E-21                                2                                               5E-24            Curated                                     MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  GLA         Galactosidase alpha                                         2.94                                        3.10      1.9                                  2E-11                                2.2                                             1E-12            Highly likely                               MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  SEMA3F      Semaphorin 3F                                               2.01                                        2.57      1.9                                  6E-43                                1.8                                             2E-15            Curated                                     --
  PRSS42      Protease, serine, 42                                        1.54                                        1.45      1.8                                  6E-10                                1.9                                             1E-08            Curated                                     --
  CRISPLD2    Cysteine-rich secretory protein LCCL domain containing 2    3.31                                        3.91      1.8                                  2E-23                                2                                               7E-13            Curated                                     --
  C8G         Complement component 8, gamma polypeptide                   1.79                                        2.00      1.8                                  3E-08                                1.7                                             9E-10            Curated                                     --
  LCN10       Lipocalin 10                                                0.42                                        0.60      1.8                                  5E-08                                1.5                                             3E-04            Curated                                     --
  PVRL2       Nectin cell adhesion molecule 2                             2.3                                         3.25      1.8                                  2E-43                                1.7                                             1E-18            Highly likely                               MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  HAPLN3      Hyaluronan and proteoglycan link protein 3                  0.89                                        1.14      1.8                                  2E-10                                1.9                                             2E-07            Curated                                     --
  ADM5        Adrenomedullin 5 (putative)                                 0.3                                         0.39      1.7                                  4E-06                                1.6                                             9E-07            Curated                                     --
  STC2        Stanniocalcin 2                                             0.31                                        0.41      1.7                                  8E-08                                2                                               2E-12            Curated                                     MS hSkMC[i](#tbl1fni){ref-type="table-fn"}
  IFI30       Interferon, gamma-inducible protein 30                      2.02                                        2.43      1.7                                  4E-15                                1.9                                             6E-08            Curated                                     MS hSkMC[i](#tbl1fni){ref-type="table-fn"}
  SERPINA3    Serpin peptidase inhibitor, clade A, member 3               0.51                                        0.53      1.7                                  3E-04                                2.7                                             4E-05            Curated                                     --
  NFAM1       NFAT activating protein with ITAM motif 1                   0.17                                        0.22      1.7                                  1E-06                                1.9                                             1E-08            Highly likely                               --
  SEMA7A      Semaphorin 7A, GPI membrane anchor                          0.57                                        0.64      1.7                                  1E-15                                1.9                                             3E-11            Curated                                     MS hSkMC[i](#tbl1fni){ref-type="table-fn"}
  GABRE       Gamma-aminobutyric acid type A receptor epsilon subunit     0.63                                        0.77      1.7                                  4E-17                                1.8                                             1E-21            Highly likely                               --
  IL1R1       Interleukin 1 receptor, type I                              2.49                                        2.86      1.7                                  7E-12                                2.1                                             2E-12            Curated                                     --
  FCGR2A      Fc fragment of IgG receptor IIa                             0.38                                        0.61      1.6                                  2E-04                                1.6                                             2E-05            Highly likely                               --
  QPCT        Glutaminyl-peptide cyclotransferase                         0.37                                        0.68      1.6                                  1E-05                                1.3                                             3E-03            Curated                                     MS hSkMC[i](#tbl1fni){ref-type="table-fn"}
  TNC         Tenascin C                                                  0.37                                        0.60      1.6                                  1E-04                                2                                               3E-04            Curated                                     MS hSkMC[i](#tbl1fni){ref-type="table-fn"}
  SLC39A14    Solute carrier family 39 member 14                          1.61                                        2.25      1.6                                  5E-15                                1.7                                             8E-12            Highly likely                               --
  VWA1        von Willebrand factor A domain containing 1                 1.52                                        2.80      1.6                                  2E-19                                1.3                                             2E-14            Curated                                     MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  GBP1        Guanylate binding protein 1, interferon-inducible           3.33                                        3.63      1.6                                  7E-13                                1.8                                             3E-11            Curated                                     MS hSkMC[i](#tbl1fni){ref-type="table-fn"}
  SMPDL3A     Sphingomyelin phosphodiesterase, acid-like 3A               10.06                                       10.15     1.6                                  1E-17                                1.5                                             1E-16            Curated                                     MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  LILRB3      Leukocyte immunoglobulin like receptor B3                   0.26                                        0.36      1.6                                  1E-06                                1.9                                             5E-08            Highly likely                               --
  NPTX2       Neuronal pentraxin II                                       1.09                                        0.90      1.6                                  4E-10                                1.7                                             5E-07            Curated                                     --
  VEGFC       Vascular endothelial growth factor C                        0.78                                        1.24      1.6                                  2E-08                                1.2                                             2E-02            Curated                                     Antibody array[g](#tbl1fng){ref-type="table-fn"}
  TFPI2       Tissue factor pathway inhibitor 2                           0.62                                        0.96      1.6                                  4E-03                                1.6                                             5E-04            Curated                                     --
  TGFB3       Transforming growth factor, beta 3                          2.91                                        4.05      1.6                                  5E-19                                1.6                                             2E-13            Curated                                     Antibody array[g](#tbl1fng){ref-type="table-fn"}
  TNFRSF1B    Tumor necrosis factor receptor superfamily, member 1B       3.26                                        4.32      1.6                                  2E-09                                1.9                                             2E-11            Curated                                     MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  FAM57A      Family with sequence similarity 57 member A                 0.59                                        0.87      1.6                                  4E-11                                1.4                                             9E-07            Highly likely                               --
  ADAM8       ADAM metallopeptidase domain 8                              0.3                                         0.40      1.5                                  2E-05                                1.7                                             3E-05            Highly likely                               --
  APLN        Apelin                                                      1.61                                        2.74      1.5                                  3E-06                                1.5                                             7E-10            Curated                                     --
  TIMP1       TIMP metallopeptidase inhibitor 1                           6.83                                        9.72      1.5                                  2E-09                                1.6                                             3E-06            Curated                                     Antibody array[g](#tbl1fng){ref-type="table-fn"}
  CSF2RB      Colony stimulating factor 2 receptor beta common subunit    0.34                                        0.53      1.5                                  7E-04                                1.7                                             1E-04            Highly likely                               --
  FLT1        Fms-related tyrosine kinase 1                               3.59                                        4.40      1.5                                  1E-25                                1.5                                             1E-12            Curated[e](#tbl1fne){ref-type="table-fn"}   --
  PDGFB       Platelet-derived growth factor beta polypeptide             5.5                                         8.35      1.5                                  2E-11                                1.3                                             4E-09            Curated                                     Antibody array[g](#tbl1fng){ref-type="table-fn"}
  POSTN       Periostin, osteoblast specific factor                       0.45                                        0.75      1.5                                  2E-03                                1.1                                             4E-01            Curated                                     MS hSkMC[i](#tbl1fni){ref-type="table-fn"}
  LILRA6      Leukocyte immunoglobulin like receptor A6                   0.21                                        0.26      1.4                                  2E-04                                1.5                                             6E-06            Highly likely                               --
  PLOD2       Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2           0.94                                        1.22      1.4                                  4E-07                                1.6                                             3E-08            Highly likely                               MS hSkMC[i](#tbl1fni){ref-type="table-fn"}
  CSF1        Colony stimulating factor 1 (macrophage)                    1.84                                        2.17      1.4                                  5E-04                                1.7                                             6E-06            Curated                                     Antibody array[g](#tbl1fng){ref-type="table-fn"}
  CD200       CD200 molecule                                              0.6                                         0.95      1.4                                  4E-04                                1.5                                             5E-07            Highly likely                               MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  LYZ         Lysozyme                                                    3.53                                        5.51      1.4                                  5E-04                                1.6                                             3E-04            Curated                                     --
  FCN1        Ficolin (collagen/fibrinogen domain containing) 1           0.63                                        0.55      1.4                                  7E-02                                2.4                                             1E-05            Curated                                     --
  DNAJB9      DnaJ heat shock protein family (Hsp40) member B9            9.39                                        9.01      1.3                                  7E-09                                1.5                                             2E-09            Highly likely                               MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  CXCL10      Chemokine (C-X-C motif) ligand 10                           1.33                                        1.07      1.3                                  2E-01                                1.6                                             2E-03            Curated                                     Antibody array[g](#tbl1fng){ref-type="table-fn"}
  MMP25       Matrix metallopeptidase 25                                  0.31                                        0.48      1.2                                  1E-01                                1.5                                             1E-02            Curated                                     --
  HLA-G       Major histocompatibility complex, class I, G                0.21                                        0.28      0.8                                  6E-01                                1.6                                             1E-01            Highly likely                               --
  IL1RN       Interleukin 1 receptor antagonist                           0.03                                        0.04      [f](#tbl1fnf){ref-type="table-fn"}   [f](#tbl1fnf){ref-type="table-fn"}   15.8                                            9E-21            Curated[e](#tbl1fne){ref-type="table-fn"}   MS Murine[h](#tbl1fnh){ref-type="table-fn"}
  CGA         Glycoprotein hormones, alpha polypeptide                    0.06                                        0.05      [f](#tbl1fnf){ref-type="table-fn"}   [f](#tbl1fnf){ref-type="table-fn"}   17.5                                            1E-14            Curated                                     --
  TREM1       Triggering receptor expressed on myeloid cells 1            0.03                                        0.03      [f](#tbl1fnf){ref-type="table-fn"}   [f](#tbl1fnf){ref-type="table-fn"}   5.9                                             2E-07            Curated                                     --
  LIPG        Lipase, endothelial                                         0.06                                        0.11      [f](#tbl1fnf){ref-type="table-fn"}   [f](#tbl1fnf){ref-type="table-fn"}   2.9                                             3E-07            Curated                                     --
  VNN2        Vanin 2                                                     0.14                                        0.17      [f](#tbl1fnf){ref-type="table-fn"}   [f](#tbl1fnf){ref-type="table-fn"}   2.9                                             7E-08            Highly likely                               --
  TNFRSF10C   Tumor necrosis factor receptor superfamily member 10c       0.12                                        0.19      [f](#tbl1fnf){ref-type="table-fn"}   [f](#tbl1fnf){ref-type="table-fn"}   2.8                                             3E-05            Highly likely                               --
  LRG1        Leucine-rich alpha-2-glycoprotein 1                         0.37                                        0.40      [f](#tbl1fnf){ref-type="table-fn"}   [f](#tbl1fnf){ref-type="table-fn"}   1.8                                             1E-05            Curated                                     --
  CFP         Complement factor properdin                                 0.24                                        0.33      [f](#tbl1fnf){ref-type="table-fn"}   [f](#tbl1fnf){ref-type="table-fn"}   1.7                                             1E-03            Curated                                     --
  RNF24       Ring finger protein 24                                      0.23                                        0.28      [f](#tbl1fnf){ref-type="table-fn"}   [f](#tbl1fnf){ref-type="table-fn"}   1.5                                             4E-07            Highly likely                               --
  SERPINF2    Serpin peptidase inhibitor, clade F, member 2               0.25                                        0.28      [f](#tbl1fnf){ref-type="table-fn"}   [f](#tbl1fnf){ref-type="table-fn"}   1.5                                             9E-05            Curated                                     --

Fragments per kilobase of transcript per million mapped reads.

Fold change.

False discovery rate.

Annotation in MetazSecKB.

Annotated as secreted in Swissprot, but not in MetazSecKB.

Expression level below EdgeR threshold for quantification.

Detected in conditioned medium from human skeletal muscle cells with antibody array [@bib9], [@bib10], [@bib18], [@bib19].

Detected in conditioned medium from murine muscle cells or explants with mass spectrometry analysis [@bib13], [@bib14], [@bib15], [@bib16], [@bib20], [@bib34], [@bib35], [@bib36].

Detected in conditioned medium from human skeletal muscle cells with mass spectrometry analysis [@bib9], [@bib10], [@bib11], [@bib12].

###### 

Transcripts up-regulated 2 h after 45 min acute exercise of 70% of VO~2~max.

Table 2

  Symbol      Gene name                                                   FPKM A1[a](#tbl2fna){ref-type="table-fn"}   FPKM B1   A3/A1                                B3/B1                                Metaz-SecKB[d](#tbl2fnd){ref-type="table-fn"}   Detected in CM                                                                   
  ----------- ----------------------------------------------------------- ------------------------------------------- --------- ------------------------------------ ------------------------------------ ----------------------------------------------- ------------------------------------ ------------------------------------------- --------------------------------------------------
  CGA         Glycoprotein hormones, alpha polypeptide                    0.06                                        0.05      17                                   1E-05                                [f](#tbl2fnf){ref-type="table-fn"}              [f](#tbl2fnf){ref-type="table-fn"}   Curated                                     --
  ANGPTL4     Angiopoietin-like 4                                         0.52                                        0.55      15.36                                2E-37                                14.35                                           7E-26                                Curated                                     MS hSkMC[i](#tbl2fni){ref-type="table-fn"}
  STC2        Stanniocalcin 2                                             0.31                                        0.41      7.97                                 3E-45                                5.14                                            2E-27                                Curated                                     MS hSkMC[i](#tbl2fni){ref-type="table-fn"}
  PLG         Plasminogen                                                 0.09                                        0.09      5.34                                 1E-15                                3.49                                            3E-17                                Curated                                     --
  FCGR3B      Fc fragment of IgG, low affinity IIIb, receptor (CD16b)     0.13                                        0.13      4.85                                 4E-07                                3.28                                            7E-09                                Curated                                     --
  LCN10       Lipocalin 10                                                0.42                                        0.60      3.85                                 7E-18                                2.68                                            8E-12                                Curated                                     --
  S100A8      S100 calcium binding protein A8                             1.01                                        1.24      3.69                                 3E-06                                3.0                                             4E-08                                Curated                                     --
  LCN6        Lipocalin 6                                                 0.54                                        0.87      3.65                                 1E-11                                2.25                                            2E-08                                Curated                                     --
  S100A9      S100 calcium binding protein A9                             1.97                                        2.23      3.31                                 3E-05                                2.71                                            2E-11                                Curated                                     --
  VEGFA       Vascular endothelial growth factor A                        47.33                                       50.63     3.19                                 9E-50                                1.94                                            4E-12                                Curated                                     Antibody array[g](#tbl2fng){ref-type="table-fn"}
  C8G         Complement component 8, gamma polypeptide                   1.79                                        2.00      3.18                                 4E-11                                2.49                                            2E-18                                Curated                                     --
  IL6R        Interleukin 6 receptor                                      4.42                                        4.11      3.09                                 5E-49                                2.31                                            3E-22                                Curated                                     --
  FCN3        Ficolin 3                                                   0.56                                        0.95      2.84                                 5E-13                                1.94                                            4E-12                                Curated                                     --
  WNT9A       Wingless-type MMTV integration site family, member 9A       4.9                                         5.58      2.76                                 1E-09                                2.13                                            2E-11                                Curated                                     --
  SERPINA1    Serpin peptidase inhibitor, clade A, member 1               0.16                                        0.22      2.76                                 3E-05                                1.73                                            1E-05                                Curated                                     --
  HBA2        Hemoglobin subunit alpha 2                                  5.6                                         5.80      2.69                                 1E-03                                1.25                                            4E-01                                Highly likely                               --
  DFNA5       DFNA5, deafness associated tumor suppressor                 1.12                                        1.57      2.65                                 4E-19                                1.96                                            2E-09                                Highly likely                               --
  PTGIR       Prostaglandin I2 (prostacyclin) receptor (IP)               0.25                                        0.30      2.59                                 3E-08                                2.31                                            7E-12                                Highly likely                               --
  WDR81       WD repeat domain 81                                         2.29                                        2.58      2.54                                 2E-39                                1.84                                            7E-24                                Highly likely                               --
  TNFRSF8     Tumor necrosis factor receptor superfamily member 8         0.15                                        0.20      2.44                                 2E-11                                2.05                                            5E-12                                Highly likely                               Antibody array[g](#tbl2fng){ref-type="table-fn"}
  CSF3R       Colony stimulating factor 3 receptor                        0.32                                        0.49      2.43                                 2E-04                                1.72                                            9E-06                                Curated[e](#tbl2fne){ref-type="table-fn"}   --
  SERPINA3    Serpin peptidase inhibitor, clade A, member 3               0.51                                        0.53      2.36                                 6E-06                                2.4                                             7E-06                                Curated                                     --
  ADAMTS9     ADAM metallopeptidase with thrombospondin type 1 motif 9    1.41                                        1.90      2.35                                 2E-16                                2.01                                            3E-11                                Curated                                     --
  VNN2        Vanin 2                                                     0.14                                        0.17      2.34                                 2E-02                                [f](#tbl2fnf){ref-type="table-fn"}              [f](#tbl2fnf){ref-type="table-fn"}   Highly likely                               --
  THBS1       Thrombospondin 1                                            0.4                                         0.75      2.33                                 8E-04                                1.93                                            2E-03                                Highly likely                               MS hSkMC[i](#tbl2fni){ref-type="table-fn"}
  SERPINF2    Serpin peptidase inhibitor, clade F, member 2               0.25                                        0.28      2.29                                 1E-07                                2.12                                            8E-12                                Curated                                     --
  CHGB        Chromogranin B                                              0.25                                        0.31      2.24                                 7E-03                                1.62                                            9E-02                                Curated                                     --
  TNFRSF1B    Tumor necrosis factor receptor superfamily, member 1B       3.26                                        4.32      2.23                                 9E-29                                1.75                                            4E-09                                Curated                                     MS Murine[h](#tbl2fnh){ref-type="table-fn"}
  FGF6        Fibroblast growth factor 6                                  7.46                                        6.00      2.16                                 9E-06                                1.35                                            1E-02                                Curated                                     Antibody array[g](#tbl2fng){ref-type="table-fn"}
  ANGPTL2     Angiopoietin like 2                                         13.79                                       18.98     2.14                                 1E-25                                1.73                                            7E-13                                Curated                                     MS Murine[h](#tbl2fnh){ref-type="table-fn"}
  SMPDL3A     Sphingomyelin phosphodiesterase, acid-like 3A               10.06                                       10.15     2.06                                 3E-10                                1.59                                            4E-11                                Curated                                     MS Murine[h](#tbl2fnh){ref-type="table-fn"}
  FAM20C      Family with sequence similarity 20, member C                7.55                                        7.82      2.05                                 2E-28                                1.57                                            2E-11                                Curated                                     MS Murine[h](#tbl2fnh){ref-type="table-fn"}
  SLC39A14    Solute carrier family 39 member 14                          1.61                                        2.25      2.03                                 5E-10                                1.79                                            4E-10                                Highly likely                               --
  RELT        RELT tumor necrosis factor receptor                         3.3                                         2.90      2.01                                 4E-12                                1.8                                             8E-10                                Highly likely                               --
  SDC4        Syndecan 4                                                  16.5                                        15.64     2                                    8E-06                                1.45                                            6E-04                                Curated                                     MS hSkMC[i](#tbl2fni){ref-type="table-fn"}
  SAA1        Serum amyloid A1                                            1.64                                        4.05      1.98                                 5E-02                                1.74                                            2E-01                                Curated                                     --
  POR         Cytochrome p450 oxidoreductase                              4.25                                        5.27      1.95                                 1E-20                                1.65                                            2E-10                                Highly likely                               MS Murine[h](#tbl2fnh){ref-type="table-fn"}
  FCGR2A      Fc fragment of IgG receptor IIa                             0.38                                        0.61      1.94                                 4E-06                                1.43                                            1E-03                                Highly likely                               --
  CES3        Carboxylesterase 3                                          8.67                                        7.90      1.9                                  6E-17                                1.63                                            3E-09                                Highly likely                               --
  VWA1        von Willebrand factor A domain containing 1                 1.52                                        2.80      1.9                                  2E-15                                1.44                                            1E-08                                Curated                                     MS Murine[h](#tbl2fnh){ref-type="table-fn"}
  INHBE       Inhibin, beta E                                             0.42                                        0.66      1.87                                 5E-05                                1.34                                            2E-02                                Curated                                     --
  ADAM8       ADAM metallopeptidase domain 8                              0.3                                         0.40      1.84                                 2E-04                                1.38                                            2E-03                                Highly likely                               --
  FCN1        Ficolin 1                                                   0.63                                        0.55      1.83                                 1E-02                                1.67                                            4E-03                                Curated                                     --
  PTTG1IP     Pituitary tumor-transforming 1 interacting protein          15.52                                       18.94     1.79                                 2E-20                                1.42                                            2E-11                                Highly likely                               --
  TOR3A       Torsin family 3 member A                                    5.87                                        6.83      1.77                                 6E-10                                1.8                                             3E-16                                Highly likely                               --
  ADM         Adrenomedullin                                              2.76                                        3.71      1.77                                 2E-05                                1.19                                            2E-01                                Curated                                     MS hSkMC[i](#tbl2fni){ref-type="table-fn"}
  PRG4        Proteoglycan 4                                              0.4                                         0.66      1.74                                 8E-02                                1.05                                            9E-01                                Curated                                     MS hSkMC[i](#tbl2fni){ref-type="table-fn"}
  PDE7A       Phosphodiesterase 7A                                        9.57                                        9.09      1.73                                 4E-17                                1.65                                            9E-19                                Highly likely                               --
  NFAM1       NFAT activating protein with ITAM motif 1                   0.17                                        0.22      1.72                                 2E-05                                1.26                                            5E-03                                Highly likely                               --
  PFKP        Phosphofructokinase, platelet                               2.44                                        3.11      1.71                                 3E-12                                1.43                                            2E-06                                Highly likely                               MS Murine[h](#tbl2fnh){ref-type="table-fn"}
  SEMA3G      Semaphorin 3G                                               4.88                                        7.13      1.7                                  4E-11                                1.34                                            2E-05                                Curated                                     MS Murine[h](#tbl2fnh){ref-type="table-fn"}
  LPL         Lipoprotein lipase                                          20.1                                        25.10     1.69                                 5E-12                                1.74                                            6E-20                                Curated                                     MS Murine[h](#tbl2fnh){ref-type="table-fn"}
  FKBP7       FK506 binding protein 7                                     1.14                                        1.24      1.69                                 5E-12                                1.43                                            7E-11                                Highly likely                               MS Murine[h](#tbl2fnh){ref-type="table-fn"}
  SRGN        Serglycin                                                   7.81                                        11.94     1.68                                 1E-12                                1.26                                            6E-04                                Curated                                     MS hSkMC[i](#tbl2fni){ref-type="table-fn"}
  TGFB3       Transforming growth factor, beta 3                          2.91                                        4.05      1.68                                 2E-14                                1.59                                            5E-14                                Curated                                     Antibody array[g](#tbl2fng){ref-type="table-fn"}
  SAA2        Serum amyloid A2                                            0.21                                        0.26      1.67                                 1E-01                                2.13                                            5E-03                                Curated                                     --
  SFRP2       Secreted frizzled-related protein 2                         0.33                                        0.73      1.67                                 3E-02                                1.01                                            1E+00                                Curated                                     MS Murine[h](#tbl2fnh){ref-type="table-fn"}
  STC1        Stanniocalcin 1                                             0.12                                        0.22      1.67                                 6E-02                                1.12                                            7E-01                                Curated                                     MS Murine[h](#tbl2fnh){ref-type="table-fn"}
  ADAMTS4     ADAM metallopeptidase with thrombospondin type 1 motif, 4   0.38                                        0.58      1.65                                 2E-03                                1.45                                            4E-02                                Curated                                     MS Murine[h](#tbl2fnh){ref-type="table-fn"}
  TEK         TEK tyrosine kinase, endothelial                            3.71                                        5.23      1.63                                 6E-17                                1.4                                             1E-07                                Curated                                     --
  CNTFR       Ciliary neurotrophic factor receptor                        14.48                                       11.88     1.62                                 1E-08                                1.45                                            5E-07                                Highly likely                               --
  FAM57A      Family with sequence similarity 57 member A                 0.59                                        0.87      1.61                                 1E-05                                1.27                                            2E-03                                Highly likely                               --
  SLC45A4     Solute carrier family 45 member 4                           0.61                                        0.76      1.61                                 2E-07                                1.32                                            4E-06                                Highly likely                               --
  SLC6A8      Solute carrier family 6 member 8                            41.86                                       38.87     1.6                                  6E-29                                1.34                                            5E-07                                Highly likely                               --
  SFRP1       Secreted frizzled-related protein 1                         0.36                                        0.32      1.6                                  7E-03                                1.5                                             9E-03                                Curated                                     --
  SLPI        Secretory leukocyte peptidase inhibitor                     1.63                                        1.06      1.6                                  8E-03                                [f](#tbl2fnf){ref-type="table-fn"}              [f](#tbl2fnf){ref-type="table-fn"}   Curated                                     MS Murine[h](#tbl2fnh){ref-type="table-fn"}
  CD163L1     CD163 molecule-like 1                                       0.16                                        0.29      1.6                                  5E-03                                1.76                                            6E-08                                Curated                                     --
  APLN        Apelin                                                      1.61                                        2.74      1.58                                 8E-04                                1.49                                            3E-03                                Curated                                     --
  TNFRSF12A   Tumor necrosis factor receptor superfamily member 12A       6.53                                        10.35     1.58                                 6E-03                                1.05                                            8E-01                                Highly likely                               --
  CCL2        Chemokine (C-C motif) ligand 2                              2.25                                        3.31      1.58                                 4E-02                                1.35                                            1E-01                                Curated                                     Antibody array[g](#tbl2fng){ref-type="table-fn"}
  GLA         Galactosidase alpha                                         2.94                                        3.10      1.57                                 3E-06                                1.37                                            6E-05                                Highly likely                               MS Murine[h](#tbl2fnh){ref-type="table-fn"}
  MTRNR2L6    MT-RNR2-like 6                                              19.29                                       22.12     1.56                                 8E-08                                1.27                                            5E-03                                Curated                                     --
  IFI30       Interferon, gamma-inducible protein 30                      2.02                                        2.43      1.56                                 9E-04                                1.46                                            4E-04                                Curated                                     MS hSkMC[i](#tbl2fni){ref-type="table-fn"}
  PLA2G15     Phospholipase A2, group XV                                  8.45                                        9.28      1.55                                 2E-12                                1.39                                            4E-09                                Curated                                     MS Murine[h](#tbl2fnh){ref-type="table-fn"}
  LOXL2       Lysyl oxidase-like 2                                        1.1                                         2.64      1.55                                 2E-07                                1.4                                             3E-06                                Curated                                     MS hSkMC[i](#tbl2fni){ref-type="table-fn"}
  METRNL      Meteorin, glial cell differentiation regulator-like         1.37                                        1.68      1.54                                 5E-03                                1.33                                            2E-02                                Curated                                     MS Murine[h](#tbl2fnh){ref-type="table-fn"}
  GFPT2       Glutamine-fructose-6-phosphate transaminase 2               1.04                                        1.15      1.54                                 3E-03                                1.31                                            2E-02                                Highly likely                               --
  ST3GAL1     ST3 beta-galactoside alpha-2,3-sialyltransferase 1          14.1                                        14.03     1.53                                 1E-14                                1.41                                            3E-11                                Curated                                     MS Murine[h](#tbl2fnh){ref-type="table-fn"}
  ADIPOQ      Adiponectin, C1Q and collagen domain containing             0.29                                        0.28      1.52                                 1E-01                                1.19                                            5E-01                                Curated                                     --
  NRG2        Neuregulin 2                                                0.41                                        0.40      1.51                                 5E-03                                1.47                                            6E-06                                Curated                                     --
  CEACAM1     Carcinoembryonic antigen-related cell adhesion molecule 1   0.62                                        0.69      1.51                                 3E-04                                1.62                                            2E-08                                Curated[e](#tbl2fne){ref-type="table-fn"}   --
  MTRNR2L4    MT-RNR2-like 4                                              68.77                                       74.18     1.5                                  3E-09                                1.36                                            5E-15                                Curated                                     --
  CD300LG     CD300 molecule like family member g                         4.55                                        7.60      1.5                                  2E-09                                1.15                                            3E-02                                Highly likely                               --
  NPTX2       Neuronal pentraxin II                                       1.09                                        0.90      1.5                                  1E-03                                1.57                                            1E-04                                Curated                                     --
  TLR9        Toll like receptor 9                                        0.62                                        0.40      1.3                                  3E-02                                1.71                                            3E-06                                Highly likely                               --
  FCGR3A      Fc fragment of IgG, low affinity IIIa, receptor (CD16a)     0.59                                        0.62      1.29                                 1E-01                                1.52                                            2E-04                                Curated                                     --
  PLAUR       Plasminogen activator, urokinase receptor                   0.3                                         0.46      1.4                                  3E-02                                1.51                                            2E-03                                Curated                                     MS Murine[h](#tbl2fnh){ref-type="table-fn"}
  CLCF1       Cardiotrophin-like cytokine factor 1                        0.22                                        0.32      [f](#tbl2fnf){ref-type="table-fn"}   [f](#tbl2fnf){ref-type="table-fn"}   1.98                                            9E-11                                Curated                                     --
  FJX1        Four jointed box 1                                          0.18                                        0.35      [f](#tbl2fnf){ref-type="table-fn"}   [f](#tbl2fnf){ref-type="table-fn"}   1.69                                            3E-05                                Curated                                     --
  HLA-G       Major histocompatibility complex, class I, G                0.21                                        0.28      0.57                                 2E-01                                1.53                                            1E-01                                Highly likely                               --
  LILRB3      Leukocyte immunoglobulin like receptor B3                   0.3                                         0.36      [f](#tbl2fnf){ref-type="table-fn"}   [f](#tbl2fnf){ref-type="table-fn"}   1.51                                            2E-04                                Highly likely                               --

Fragments per kilobase of transcript per million mapped reads.

Fold change.

False discovery rate.

Annotation in MetazSecKB.

Annotated as secreted in Swissprot, but not in MetazSecKB.

Expression level below EdgeR threshold for quantification.

Detected in conditioned medium from human skeletal muscle cells with antibody array [@bib9], [@bib10], [@bib18], [@bib19].

Detected in conditioned medium from murine muscle cells or explants with mass spectrometry analysis [@bib13], [@bib14], [@bib15], [@bib16], [@bib20], [@bib34], [@bib35], [@bib36].

Detected in conditioned medium from human skeletal muscle cells with mass spectrometry analysis [@bib9], [@bib10], [@bib11], [@bib12].

###### 

Transcripts up-regulated after 12 weeks exercise intervention.

Table 3

  Symbol      Gene name                                                           FPKM A1[a](#tbl3fna){ref-type="table-fn"}   B1/A1   MetazSecKB[d](#tbl3fnd){ref-type="table-fn"}   Detected in CM                              
  ----------- ------------------------------------------------------------------- ------------------------------------------- ------- ---------------------------------------------- ------------------------------------------- ---------------------------------------------------
  SFRP5       Secreted frizzled-related protein 5                                 0.31                                        4.84    1E-01                                          Curated                                     --
  MXRA5       Matrix-remodelling associated 5                                     0.48                                        2.75    3E-14                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  THY1        Thy-1 cell surface antigen                                          1.7                                         2.44    3E-14                                          Highly likely                               --
  CPXM1       Carboxypeptidase X (M14 family), member 1                           0.2                                         2.43    2E-04                                          Curated                                     --
  COL1A1      Collagen, type I, alpha 1                                           4.92                                        2.4     8E-18                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  COL3A1      Collagen, type III, alpha 1                                         16.73                                       2.4     4E-17                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  COL4A1      Collagen, type IV, alpha 1                                          14.09                                       2.36    2E-26                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  THBS4       Thrombospondin 4                                                    21.74                                       2.21    1E-19                                          Curated                                     --
  SFRP2       Secreted frizzled-related protein 2                                 0.33                                        2.18    1E-07                                          Curated                                     MS Murine cells[g](#tbl3fng){ref-type="table-fn"}
  LOXL2       Lysyl oxidase-like 2                                                1.1                                         2.18    3E-24                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  COL4A2      Collagen, type IV, alpha 2                                          13.41                                       2.17    4E-25                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  BGN         Biglycan                                                            2.86                                        2.1     2E-15                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  OGN         Osteoglycin                                                         0.62                                        2.09    6E-07                                          Curated                                     MS Murine cells[g](#tbl3fng){ref-type="table-fn"}
  CCL21       Chemokine (C-C motif) ligand 21                                     0.35                                        2.07    6E-02                                          Curated                                     Antibody array[f](#tbl3fnf){ref-type="table-fn"}
  COL6A6      Collagen, type VI, alpha 6                                          0.1                                         2.04    3E-07                                          Curated                                     --
  AMICA1      Adhesion molecule, interacts with CXADR antigen 1                   0.3                                         2.0     5E-09                                          Highly likely                               --
  IGF2        Insulin-like growth factor 2                                        0.7                                         1.98    3E-21                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  LOX         Lysyl oxidase                                                       0.3                                         1.96    4E-23                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  TMEM119     Transmembrane protein 119                                           0.4                                         1.96    3E-13                                          Highly likely                               MS Murine cells[g](#tbl3fng){ref-type="table-fn"}
  CDH24       Cadherin 24, type 2                                                 0.27                                        1.95    3E-08                                          Highly likely                               --
  PXDN        Peroxidasin                                                         3                                           1.94    5E-29                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  VIPR1       Vasoactive intestinal peptide receptor 1                            0.41                                        1.9     3E-10                                          Highly likely                               --
  WISP1       WNT1 inducible signaling pathway protein 1                          0.14                                        1.86    3E-10                                          Curated                                     MS Murine cells[g](#tbl3fng){ref-type="table-fn"}
  ADAMTS7     ADAM metallopeptidase with thrombospondin type 1 motif, 7           0.52                                        1.85    9E-19                                          Curated                                     MS Murine cells[g](#tbl3fng){ref-type="table-fn"}
  ASPN        Asporin                                                             2.45                                        1.83    1E-15                                          Curated                                     MS Murine cells[g](#tbl3fng){ref-type="table-fn"}
  NRP2        Neuropilin 2                                                        0.53                                        1.83    3E-19                                          Curated                                     MS Murine cells[g](#tbl3fng){ref-type="table-fn"}
  ST8SIA2     ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2        0.09                                        1.82    5E-03                                          Highly likely                               MS Murine cells[g](#tbl3fng){ref-type="table-fn"}
  QPCT        Glutaminyl-peptide cyclotransferase                                 0.37                                        1.81    3E-07                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  IL10RA      Interleukin 10 receptor, alpha                                      0.7                                         1.8     5E-12                                          Highly likely                               Antibody array[f](#tbl3fnf){ref-type="table-fn"}
  COL14A1     Collagen, type XIV, alpha 1                                         0.62                                        1.78    7E-10                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  OMD         Osteomodulin                                                        0.31                                        1.78    8E-06                                          Curated                                     MS Murine cells[g](#tbl3fng){ref-type="table-fn"}
  SFRP4       Secreted frizzled-related protein 4                                 2.51                                        1.77    5E-05                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  F2R         Coagulation factor II receptor                                      1.5                                         1.77    2E-26                                          Highly likely                               --
  PTN         Pleiotrophin                                                        0.62                                        1.77    1E-07                                          Curated                                     MS Murine cells[g](#tbl3fng){ref-type="table-fn"}
  COL1A2      Collagen, type I, alpha 2                                           16.05                                       1.76    1E-10                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  SPARC       Secreted protein, acidic, cysteine-rich                             71.53                                       1.76    5E-24                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  ANGPTL7     Angiopoietin-like 7                                                 0.34                                        1.74    4E-01                                          Curated                                     --
  LAMB1       Laminin, beta 1                                                     6.8                                         1.74    3E-16                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  CTHRC1      Collagen triple helix repeat containing 1                           1.34                                        1.73    2E-10                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  PAMR1       Peptidase domain containing associated with muscle regeneration 1   0.86                                        1.73    7E-05                                          Curated                                     --
  LAMA4       Laminin, alpha 4                                                    2.95                                        1.72    1E-32                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  MEST        Mesoderm specific transcript                                        1.24                                        1.71    2E-07                                          Highly likely                               --
  NID2        Nidogen 2 (osteonidogen)                                            2.27                                        1.71    3E-22                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  VWA1        von Willebrand factor A domain containing 1                         1.52                                        1.71    1E-15                                          Curated                                     MS Murine cells[g](#tbl3fng){ref-type="table-fn"}
  LAMC3       Laminin, gamma 3                                                    0.09                                        1.7     1E-03                                          Curated                                     --
  GPR162      G protein-coupled receptor 162                                      0.44                                        1.69    8E-10                                          Highly likely                               --
  ADCYAP1R1   Adenylate cyclase activating polypeptide 1 receptor type I          0.3                                         1.68    1E-11                                          Highly likely                               --
  KCP         Kielin/chordin-like protein                                         0.2                                         1.67    1E-07                                          Curated                                     --
  ITIH3       Inter-alpha-trypsin inhibitor heavy chain 3                         0.46                                        1.66    9E-05                                          Curated                                     --
  HEPH        Hephaestin                                                          0.26                                        1.66    2E-08                                          Highly likely                               MS Murine cells[g](#tbl3fng){ref-type="table-fn"}
  IGFBP3      Insulin-like growth factor binding protein 3                        3.48                                        1.66    5E-16                                          Curated                                     Antibody array[f](#tbl3fnf){ref-type="table-fn"}
  VMO1        Vitelline membrane outer layer 1 homolog                            1.54                                        1.65    3E-01                                          Curated                                     --
  CD163L1     CD163 molecule-like 1                                               0.16                                        1.65    1E-05                                          Curated                                     --
  CD300LG     CD300 molecule-like family member g                                 4.55                                        1.64    1E-23                                          Highly likely                               --
  FCGR2B      Fc fragment of IgG, low affinity IIb, receptor                      0.44                                        1.63    3E-05                                          Highly likely                               --
  AGRN        Agrin                                                               1.88                                        1.63    9E-19                                          Curated[e](#tbl3fne){ref-type="table-fn"}   MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  ADAMTS15    ADAM metallopeptidase with thrombospondin type 1 motif, 15          0.78                                        1.63    3E-20                                          Curated                                     --
  KAZALD1     Kazal-type serine peptidase inhibitor domain 1                      2.08                                        1.62    7E-14                                          Curated                                     MS Murine cells[g](#tbl3fng){ref-type="table-fn"}
  APLN        Apelin                                                              1.61                                        1.62    9E-07                                          Curated                                     --
  EMILIN3     Elastin microfibril interfacer 3                                    0.35                                        1.61    1E-03                                          Curated                                     --
  COL5A2      Collagen, type V, alpha 2                                           2.94                                        1.59    2E-11                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  ECM2        Extracellular matrix protein 2                                      1.86                                        1.58    4E-15                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  THBS1       Thrombospondin 1                                                    0.4                                         1.58    2E-05                                          Highly likely                               MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  FGFR3       Fibroblast growth factor receptor 3                                 0.13                                        1.58    2E-04                                          Curated[e](#tbl3fne){ref-type="table-fn"}   --
  ADAMTS8     ADAM metallopeptidase with thrombospondin type 1 motif, 8           0.26                                        1.58    1E-03                                          Curated                                     --
  SERPINE1    Serpin peptidase inhibitor, clade E, member 1                       0.78                                        1.57    7E-06                                          Curated                                     Antibody array[f](#tbl3fnf){ref-type="table-fn"}
  ADAMTSL3    ADAMTS-like 3                                                       0.84                                        1.57    2E-13                                          Curated                                     MS Murine cells[g](#tbl3fng){ref-type="table-fn"}
  NID1        Nidogen 1                                                           4.32                                        1.57    4E-16                                          Curated                                     Antibody array[f](#tbl3fnf){ref-type="table-fn"}
  ADAMTS2     ADAM metallopeptidase with thrombospondin type 1 motif, 2           0.34                                        1.57    1E-05                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  OLFML2B     Olfactomedin-like 2B                                                2.82                                        1.57    2E-07                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  IGFBP2      Insulin-like growth factor binding protein 2                        4                                           1.56    5E-10                                          Curated                                     Antibody array[f](#tbl3fnf){ref-type="table-fn"}
  KDR         Kinase insert domain receptor                                       2.34                                        1.56    1E-20                                          Curated                                     --
  EDN1        Endothelin 1                                                        0.66                                        1.56    2E-05                                          Curated                                     Antibody array[f](#tbl3fnf){ref-type="table-fn"}
  GRIN2C      Glutamate receptor, ionotropic, N-methyl D-aspartate 2C             0.17                                        1.56    5E-05                                          Highly likely                               --
  SERPINH1    Serpin peptidase inhibitor, clade H, member 1                       6.71                                        1.55    4E-18                                          Highly likely                               MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  HSPG2       Heparan sulfate proteoglycan 2                                      12.38                                       1.55    3E-19                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  SCT         Secretin                                                            7.26                                        1.55    4E-03                                          Curated                                     --
  LOXL3       Lysyl oxidase-like 3                                                0.44                                        1.55    9E-07                                          Curated                                     MS Murine cells[g](#tbl3fng){ref-type="table-fn"}
  TNFRSF25    Tumor necrosis factor receptor superfamily, member 25               2                                           1.54    8E-13                                          Curated                                     --
  ACE         Angiotensin I converting enzyme                                     5.22                                        1.54    3E-17                                          Curated[e](#tbl3fne){ref-type="table-fn"}   --
  MMP14       Matrix metallopeptidase 14                                          2.66                                        1.54    1E-13                                          Highly likely                               MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  CSF1R       Colony stimulating factor 1 receptor                                1.84                                        1.54    3E-07                                          Highly likely                               --
  TYRP1       Tyrosinase-related protein 1                                        0.78                                        1.53    1E-02                                          Highly likely                               --
  IGSF10      Immunoglobulin superfamily, member 10                               0.08                                        1.53    8E-04                                          Curated                                     MS Murine cells[g](#tbl3fng){ref-type="table-fn"}
  GREM1       Gremlin 1, DAN family BMP antagonist                                0.74                                        1.53    1E-06                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  CLEC11A     C-type lectin domain family 11, member A                            1.37                                        1.53    1E-06                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  CDH5        Cadherin 5, type 2                                                  15.17                                       1.53    1E-28                                          Highly likely                               MS Murine cells[g](#tbl3fng){ref-type="table-fn"}
  FAT1        FAT atypical cadherin 1                                             0.33                                        1.53    6E-09                                          Highly likely                               MS Murine cells[g](#tbl3fng){ref-type="table-fn"}
  FGF9        Fibroblast growth factor 9                                          0.28                                        1.53    2E-06                                          Curated                                     Antibody array[f](#tbl3fnf){ref-type="table-fn"}
  VEGFC       Vascular endothelial growth factor C                                0.78                                        1.53    4E-09                                          Curated                                     Antibody array[f](#tbl3fnf){ref-type="table-fn"}
  NOTCH4      Notch 4                                                             0.93                                        1.53    2E-32                                          Highly likely                               --
  CCDC80      Coiled-coil domain containing 80                                    3.43                                        1.52    8E-05                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  AEBP1       AE binding protein 1                                                2.14                                        1.52    2E-07                                          Curated[e](#tbl3fne){ref-type="table-fn"}   MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  COL15A1     Collagen, type XV, alpha 1                                          21                                          1.52    2E-11                                          Curated                                     MS Murine cells[g](#tbl3fng){ref-type="table-fn"}
  ELN         Elastin                                                             2.35                                        1.52    1E-07                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  COL5A1      Collagen, type V, alpha 1                                           2.73                                        1.51    2E-09                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  TYROBP      TYRO protein tyrosine kinase binding protein                        2.81                                        1.51    1E-05                                          Highly likely                               --
  LUM         Lumican                                                             9.96                                        1.51    2E-05                                          Curated                                     MS hSkMC[h](#tbl3fnh){ref-type="table-fn"}
  ISLR2       Immunoglobulin superfamily containing leucine-rich repeat 2         0.41                                        1.51    1E-06                                          Highly likely                               MS Murine cells[g](#tbl3fng){ref-type="table-fn"}

Fragments per kilobase of transcript per million mapped reads at baseline (A1).

Fold change.

False discovery rate.

Annotation in MetazSecKB.

Annotated as secreted in Swissprot, but not in MetazSecKB.

Detected in conditioned medium from human skeletal muscle cells with antibody array [@bib9], [@bib10], [@bib18], [@bib19].

Detected in conditioned medium from murine muscle cells or explants cells with mass spectrometry analysis [@bib13], [@bib14], [@bib15], [@bib16], [@bib20], [@bib34], [@bib35], [@bib36].

Detected in conditioned medium from human skeletal muscle cells with mass spectrometry analysis [@bib9], [@bib10], [@bib11], [@bib12].
